Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

SecurityVIR / Vir Biotechnology, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership985,435 shares
Latest Disclosed Value $ 8,829,496
Northern Trust Corp reports 16.14% increase in ownership of VIR / Vir Biotechnology, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 985,435 shares of Vir Biotechnology, Inc. (US:VIR) valued at $8,829,498 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 848,469 shares of Vir Biotechnology, Inc.. This represents a change in shares of 16.14% during the quarter. The current value of the position is $9,016,730 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 985,435 136,966 16.14 8,829 72.58 0.0002
2026-02-17 2025-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 848,469 -58,657 -6.47 5,116 -1.22 0.0007
2025-11-14 2025-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 907,126 -21,114 -2.27 5,180 10.71 0.0007
2025-08-13 2025-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 928,240 -2,080 -0.22 4,678 -22.40 0.0006
2025-05-13 2025-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 930,320 -134 -0.01 6,028 -11.73 0.0009
2025-02-14 2024-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 930,454 51,530 5.86 6,830 3.74 0.0010
2024-11-13 2024-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 878,924 45,433 5.45 6,583 -11.26 0.0011
2024-08-14 2024-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 833,491 -25,100 -2.92 7,418 -14.71 0.0012
2024-05-14 2024-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 858,591 -78,713 -8.40 8,698 -7.76 0.0015
2024-02-13 2023-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 937,304 -61,249 -6.13 9,429 0.78 0.0017
2023-11-13 2023-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 998,553 21,808 2.23 9,356 -60.95 0.0018
2023-08-11 2023-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 976,745 110,365 12.74 23,960 18.84 0.0046
2023-05-15 2023-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 866,380 87,681 11.26 20,161 2.29 0.0040
2023-02-13 2022-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 778,699 -51,965 -6.26 19,709 23.06 0.0041
2022-11-14 2022-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 830,664 -23,739 -2.78 16,015 -26.41 0.0037
2022-08-12 2022-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 854,403 243,076 39.76 21,762 38.40 0.0047
2022-05-13 2022-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 611,327 -8,180 -1.32 15,724 -39.38 0.0028
2022-02-08 2021-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 619,507 -3,142 -0.50 25,939 -4.28 0.0042
2021-11-15 2021-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 622,649 -28,611 -4.39 27,098 -12.00 0.0048
2021-08-13 2021-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 651,260 46,639 7.71 30,792 -0.67 0.0054
2021-05-12 2021-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 604,621 -32,392 -5.08 30,999 81.73 0.0058
2021-02-11 2020-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 637,013 -17,808 -2.72 17,058 -24.12 0.0033
2020-11-16 2020-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 654,821 164,032 33.42 22,481 11.81 0.0049
2020-08-14 2020-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 490,789 381,561 349.33 20,107 437.05 0.0048
2020-05-14 2020-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 109,228 3,476 3.29 3,744 181.50 0.0011
2020-02-14 2019-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 105,752 105,752 1,330 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.